证券代码：301277 证券简称：新天地 公告编号：2025-030 新天地药业股份有限公司 2025年第一次临时股东会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 特别提示： 1、本次股东会无否决议案的情形。 2、本次股东会未涉及变更以往股东会已通过决议的情形。 一、会议的召开和出席情况 （一）会议召开情况 1.会议召开时间 （1）现场会议时间：2025年05月08日（星期四）下午14:30。 （2）网络投票时间：2025年05月08日，其中，通过深圳证券交易所交易系 统进行网络投票的具体时间为2025年05月08日9：15—9：25，9：30—11：30 和 13：00—15：00；通过深圳证券交易所互联网投票系统投票的具体时间为2025 年05月08日9：15—15：00期间的任意时间。 1.具体出席情况如下表所示： | 出席现场 | 出席现场会议的股东及代理人人数 | 2人 | | --- | --- | --- | | 会议的情况 | 所持有公司表决权的股份总数 | 291,060,000股 | | | 占公司股本总额的比例 | 74. ...

北京市天元律师事务所 关于新天地药业股份有限公司 2025 年第一次临时股东会的法律意见 京天股字（2025）第 222 号 致：新天地药业股份有限公司 新天地药业股份有限公司（以下简称"公司"）2025 年第一次临时股东会（以 下简称"本次股东会"）采取现场投票与网络投票相结合的方式，现场会议于 2025 年 5 月 8 日在河南省长葛市魏武路南段东侧新天地药业股份有限公司会议室召开。 北京市天元律师事务所（以下简称"本所"）接受公司聘任，指派本所律师参加本 次股东会会议，并根据《中华人民共和国公司法》《中华人民共和国证券法》（以 下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股东会规则》"） 以及《新天地药业股份有限公司章程》（以下简称"《公司章程》"）等有关规定， 就本次股东会的召集、召开程序、出席现场会议人员的资格、召集人资格、会议表 决程序及表决结果等事项出具本法律意见。 为出具本法律意见，本所律师审查了《新天地药业股份有限公司第六届董事会 第六次会议决议公告》《新天地药业股份有限公司第六届监事会第六次会议决议公 告》《新天地药业股份有限公司关于召开 2025 年第一次临时股东会的通知 ...

Group 1 - Geely Auto proposed to privatize Zeekr with an offer of $2.57 per share, representing a 13.6% premium over the last trading price [1] - The offer also includes a premium of 20.0% over the volume-weighted average price of the last 30 trading days [1] - Geely currently holds approximately 65.7% of Zeekr's issued share capital [1] Group 2 - Sun Group announced the U.S. Department of Commerce has revoked its investigation into steel wheels made in Vietnam using Chinese components [2] - The revocation is expected to positively impact the company's export orders and future overseas business layout [2] Group 3 - Qingdao Beer plans to acquire 100% equity of Jimo Yellow Wine for a total consideration of RMB 665 million [3] - The acquisition aims to enhance industry synergy, competitiveness, and expand product lines and market channels [3] Group 4 - BeiGene reported a net loss of 94.503 million yuan in Q1 2025, a reduction in loss compared to the previous year [4] - The company achieved total revenue of 8.048 billion yuan, a year-on-year increase of 50.2%, driven by sales growth of its self-developed products [4] Group 5 - Daqin Railway reported a 0.99% year-on-year increase in cargo transportation volume for April [5] - Shaanxi Coal's self-produced coal sales reached 13.1033 million tons in April, up 0.76% year-on-year [5] Group 6 - Shennong Group sold 227,300 pigs in April, marking a 32.85% year-on-year increase [6] - Poly Developments reported a 25.44% year-on-year decrease in contracted sales amounting to 24.622 billion yuan in April [6] Group 7 - Hainan Development plans to acquire 51% equity of Wangying Technology [7] - Huafeng Measurement Control's shareholders plan to transfer 2.9% of shares at an initial price of 121.42 yuan per share [7] Group 8 - Various companies reported significant stock price fluctuations, with Changshan Pharmaceutical's injection not yet on the market and facing regulatory uncertainties [8] - The company is in the professional review stage for its diabetes treatment application [8]

Group 1: Company Performance - Wens Foodstuff's April chicken sales revenue was 2.543 billion yuan, a year-on-year decrease of 5.01% [1] - Wens Foodstuff sold 10.381 million chickens in April, a year-on-year increase of 10.87% [1] - Wens Foodstuff's average chicken selling price was 11.24 yuan/kg, a year-on-year decrease of 14.91% [1] - Zhongtong Bus's April vehicle sales volume was 1,046 units, a year-on-year decrease of 4.04% [1][2] - Kemin Food's April pig sales revenue reached 70.9048 million yuan, a year-on-year increase of 16.04% [3] - Muyuan Foods sold 6.573 million pigs in April, a year-on-year increase of 51.80% [5] - Muyuan Foods' pig sales revenue was 12.595 billion yuan in April, a year-on-year increase of 53.42% [5] - Xiamen Airport's April passenger throughput was 2.3881 million, a year-on-year increase of 7.73% [24] - Daqin Railway's April cargo transport volume was 30.62 million tons, a year-on-year increase of 0.99% [26] - Shaanxi Coal's April coal production was 14.24 million tons, a year-on-year decrease of 1.78% [28] Group 2: Industry Overview - Wens Foodstuff operates in the agriculture, forestry, animal husbandry, and fishery industry, specifically in pig farming [1] - Zhongtong Bus operates in the automotive industry, focusing on commercial vehicles [2] - Kemin Food operates in the food and beverage industry, specifically in food processing [3] - Muyuan Foods is also in the agriculture, forestry, animal husbandry, and fishery industry, focusing on pig farming [5] - Xiamen Airport is part of the transportation industry, specifically in airport operations [24] - Daqin Railway operates in the coal industry, focusing on coal mining and transportation [26] - Shaanxi Coal is also in the coal industry, focusing on coal mining and related services [28]

Core Viewpoint - The company has received approval from the National Medical Products Administration for the raw material drug Sulfhydryl Clopidogrel, indicating compliance with Chinese drug review standards and enhancing the company's product portfolio [1] Group 1: Regulatory Approval - The company received the approval notice for Sulfhydryl Clopidogrel on May 6, 2025 [1] - The approval allows the raw material to be used in domestic formulations, expanding the company's product offerings [1] - The approval notice is valid until May 5, 2030 [1] Group 2: Product Information - Sulfhydryl Clopidogrel is a commonly used antiplatelet drug [1] - It is primarily used for the prevention and treatment of cardiovascular diseases related to atherosclerotic thrombosis [1] - The drug works by inhibiting platelet aggregation to reduce the risk of thrombosis [1]

证券代码：301277 证券简称：新天地 公告编号：2025-029 | 化学原料药名称 | 通用名称：硫酸氢氯吡格雷 英文名/拉丁名：Clopidogrel Bisulfate | | --- | --- | | 通知书编号 | 2025YS00364 | | 登记号 | Y20230001350 | | 有效期 | 18个月 | | 包装规格 | 1kg/桶、5kg/桶、10kg/桶、15kg/桶、25kg/桶 | | 申请事项 | 境内生产化学原料药上市申请 | | 审批结论 | 根据《中华人民共和国药品管理法》及有关规定，经审查，本 品符合药品注册的有关要求，批准注册。质量标准、标签及生 | | | 产工艺照所附执行。 | | 生产企业 | 名称：新天地药业股份有限公司 | | | 地址：长葛市魏武路南段东侧 | | 通知书有效期 | 至2030年5月5日 | 一 、药品信息 1 二 、药品的其他情况 新天地药业股份有限公司 关于获得化学原料药上市申请批准通知书的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 2025年05月06日，新天地药业 ...

Group 1 - The article highlights the emergence of a trillion-dollar low-altitude economy in China, exemplified by innovative agricultural practices using drones in Xi'an [2][8] - The integration of industry and education is showcased through a collaborative research platform between universities and enterprises, enhancing research efficiency and technology transfer [4][5] - The establishment of a supportive policy environment has significantly improved the overall effectiveness of the innovation system, facilitating breakthroughs in various sectors [6] Group 2 - The article discusses the role of funding in revitalizing dormant scientific research, with specific examples of companies achieving domestic production capabilities in magnetic materials [8][9] - The establishment of a drone test flight base in Xi'an has attracted multiple companies and is expanding low-altitude application scenarios, including logistics and inspection services [9][10] - The region has successfully attracted 37 companies in the intelligent connected vehicle industry, contributing to a projected total output value of over 4 billion yuan in 2024 [10]

新天地药业股份有限公司（以下简称"公司"）于近日收到保荐机构华泰联 合证券有限责任公司（以下简称"华泰联合"）出具的《华泰联合证券有限责任 公司关于更换新天地药业股份有限公司首次公开发行股票持续督导保荐代表人 的函》，华泰联合作为公司首次公开发行股票并在创业板上市项目的保荐机构， 原指定卢旭东先生、刘栋先生担任持续督导保荐代表人，负责公司持续督导工作， 持续督导期至2025年12月31日结束。 证券代码：301277 证券简称：新天地 公告编号：2025-028 新天地药业股份有限公司 关于变更保荐代表人的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 现因卢旭东先生工作变动，不再继续担任公司持续督导的保荐代表人，为 保证持续督导工作的有序进行，华泰联合决定由刘天际先生（简历详见附件）接 替卢旭东先生担任公司的持续督导保荐代表人，继续履行持续督导职责。 本次保荐代表人变更后，公司首次公开发行股票并在创业板上市项目持续 督导保荐代表人为刘栋先生、刘天际先生。 公司董事会对卢旭东先生在公司首次公开发行股票并在创业板上市及持续 督导期间所做出的贡献表示衷心感 ...

证券代码：301277 证券简称：新天地 公告编号：2025-027 新天地药业股份有限公司 1 | | 原料药盐酸罗哌卡因符合药品生产质量管理规范 | | --- | --- | | 检查结论 | （2010年修订）要求[生产车间、生产线：原料药202 | | | 车间，盐酸罗哌卡因202-5生产线（合成）、盐酸罗 | | | 哌卡因202-3生产线（精制）]。 | 盐酸罗哌卡因是一种长效酰胺类局麻药，有麻醉和镇痛双重效应，药理机 制包括阻滞神经传导、抑制疼痛信号传递等。广泛用于外科手术麻醉：硬膜外 麻醉，包括剖宫产术；蛛网膜下腔麻醉、区域阻滞。 公司盐酸罗哌卡因原料药通过药品GMP符合性检查，表明公司相关产品和 生产线符合GMP要求，有利于推动该产品在国内生产并上市销售，完善公司产 品结构，提升生产能力，促进公司持续、健康发展。 公司将根据市场需求情况安排生产和销售，并持续保持良好的生产管理和 质量保证体系。由于国家政策、市场环境变化等因素影响，药品的生产、销售 等具体情况存在不确定性，敬请广大投资者注意风险，理性投资。 特此公告。 新天地药业股份有限公司 关于公司通过药品GMP符合性检查的公告 本公司及 ...

证券时报·数据宝统计，截至（4月24日）收盘，沪指报3297.29点，涨0.93点，涨幅为0.03%；深成指报 9878.32点，跌57.48点，跌幅为0.58%；创业板指报1935.86点，跌13.30点，跌幅为0.68%。个股方面， 今日96只A股换手率超过20%，其中，C江顺科、C天有等5只个股换手率达五成以上，半数筹码易主。 （数据宝） 4月24日两市换手率居前个股一览 | 证券代码 | 证券简称 | 收盘价（元） | 换手率（%） | 涨跌幅（%） | | --- | --- | --- | --- | --- | | 001400 | C江顺科 | 66.70 | 72.39 | 78.53 | | 603202 | C天有 | 116.00 | 70.35 | 24.06 | | 920066 | 科拜尔 | 48.65 | 59.97 | -14.47 | | 002094 | 青岛金王 | 9.14 | 57.39 | 2.24 | | 603205 | 健尔康 | 43.75 | 53.69 | 10.01 | | 301277 | 新天地 | 13.27 | 48.54 | 3.75 | ...